- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07348744
The Effect of a Health Belief Model-Based Education Program on Breast Self-Examination Practice Behavior, Breast Cancer Fear, and Awareness Levels in Women: A Randomized Controlled Trial (KAU-BSE-RCT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized controlled study aims to evaluate the effectiveness of a Health Belief Model-based education program on women's breast self-examination practices, breast cancer fear, and awareness levels. Participants will be randomly assigned to either an intervention group receiving a structured education program based on the Health Belief Model or a control group receiving usual care.
Data will be collected using a Personal Information Form, the Champion Health Belief Model Scale, the Comprehensive Breast Cancer Knowledge Test, the Breast Cancer Awareness Scale, and the Champion Breast Cancer Fear Scale at baseline and three months after the intervention. The findings of this study are expected to contribute to the development of effective educational strategies for improving breast cancer awareness and preventive health behaviors among women.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: CANSU KARADAĞ
- Phone Number: 05414233218
- Email: cansukaradag@ardahan.edu.tr
Study Locations
-
-
Kars
-
Kars, Kars, Turkey (Türkiye), 36100
- Kafkas Üniversity
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being affiliated with Family Health Center No. 1 in Ardahan Province,
- Being a woman between the ages of 20 and 69,
- Being literate,
- Not having been diagnosed with breast cancer,
- Not having a mental or communication disorder,
- Having a phone available for communication,
- Women who voluntarily agree to participate in the study.
Exclusion Criteria:
- Difficulty communicating,
- Wanting to drop out of the study,
- Not wanting to participate in the study.
- Women who did not fill out the data form despite reminders via message and phone call.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Health Belief Model-Based Education Group
Participants receive a structured education program based on the Health Belief Model focusing on breast self-examination.
|
A structured education program based on the Health Belief Model designed to improve breast self-examination behavior and increase breast cancer awareness.
|
|
No Intervention: Control Group
Participants receive usual care without any additional educational intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Breast Self-Examination Behavior
Time Frame: Baseline and 3 months after the intervention
|
Change in breast self-examination behavior measured as a single self-reported outcome indicating whether participants perform breast self-examination.
|
Baseline and 3 months after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Breast Cancer Knowledge Level
Time Frame: Baseline and 3 months after the intervention
|
Change in breast cancer knowledge assessed using the Comprehensive Breast Cancer Knowledge Test.
|
Baseline and 3 months after the intervention
|
|
Change in Breast Cancer Awareness Level
Time Frame: Baseline and 3 months after the intervention
|
Change in breast cancer awareness measured using the Breast Cancer Awareness Scale.
|
Baseline and 3 months after the intervention
|
|
Change in Breast Cancer Fear Level
Time Frame: Baseline and 3 months after the intervention
|
Change in fear related to breast cancer measured using the Champion Breast Cancer Fear Scale.
|
Baseline and 3 months after the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: CANSU KARADAĞ, Kafkas Üniversity
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KAU-BSE-RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Health Belief Model-Based Education Program
-
Aydin Adnan Menderes UniversityCompletedTHE HEALTH BELIEF MODEL ON THE PHYSICAL ACTIVITY BELIEFSTurkey
-
Ondokuz Mayıs UniversityCompletedDiabetes Mellitus | Family MembersTurkey
-
Baqiyatallah Medical Sciences UniversityCompletedOral HealthIran, Islamic Republic of
-
Muhammet Faruk YigitNot yet recruitingCervical Cancer | Human Papillomavirus Infection | Preventive Health Services
-
Sakarya UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingHealth Behaviour | Risk Behavior, Health
-
Dow University of Health SciencesCompletedDiabetes Type 2 | Oral Health Behavior Change | Oral Health KnowledgePakistan
-
Saglik Bilimleri UniversitesiCompletedEducation | Health Belief ModelTurkey (Türkiye)
-
Gazi UniversityCompleted
-
Bartın UnıversityNot yet recruitingHealth Belief Model-Based Osteoporosis Education ProgrammeTurkey (Türkiye)
-
Istanbul University - Cerrahpasa (IUC)CompletedBreastfeeding EducationTurkey